Tag: artificial intelligence (AI)-driven hospital readmission predictor market growth

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The artificial intelligence (AI)-driven hospital readmission predictor market has seen substantial growth in recent years. This market is projected to expand from $1.92 billion in 2025 to $2.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.2%. Historically, this expansion has been driven by several factors including the increasing adoption of AI in healthcare, a growing demand to reduce hospital readmissions, the rising availability of electronic health records, the broader use of predictive analytics, and an increasing focus on patient outcomes.

The market for artificial intelligence (AI)-driven hospital readmission predictors is projected to experience substantial growth in the coming years. This market is anticipated to reach $6.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 25.9%. Key factors contributing to this expansion during the forecast period include increased investments in healthcare information technology infrastructure, enhanced integration of clinical decision support systems, wider adoption of cloud-based analytics platforms, the broadening of remote patient monitoring tools, and a heightened focus on value-based care models. Significant trends observed over the forecast period encompass technological advancements in machine learning models, breakthroughs in real-time patient monitoring, ongoing research and development in natural language processing, the creation of explainable AI specifically for healthcare applications, and improvements in interoperable healthcare IT systems.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=69754376&type=smp&name=Artificial%20Intelligence%20%28AI%29-Driven%20Hospital%20Readmission%20Predictor%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Development Factors: What’s Supporting Demand?

The rising occurrence of chronic conditions is anticipated to fuel expansion in the artificial intelligence (AI)-driven hospital readmission predictor market. These are enduring medical ailments, including diabetes, heart disease, and arthritis, that typically advance gradually and necessitate continuous healthcare and lifestyle adjustments to manage indicators and avert adverse events. Their escalation is predominantly linked to detrimental lifestyle choices such as inadequate nutrition, lack of physical activity, and tobacco use, contributing to a higher likelihood of conditions like diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors assist in managing chronic illnesses by examining patient information to pinpoint individuals prone to re-hospitalization. These tools enhance patient results through facilitating early interventions, tailored care strategies, and prompt follow-up, thereby preventing complications and shortening hospital durations. For example, data from June 2024, released by the National Health Service, a UK government department, showed that 3,615,330 individuals registered with a general practitioner (GP) had a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state with elevated blood sugar, insufficient for a diabetes classification) in 2023. This represented an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the expanding incidence of chronic diseases is fueling the development of the artificial intelligence (AI)-driven hospital readmission predictor market.

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Segment Outlook: Which Categories Are Growing Fastest?

The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud

3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools

2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices

3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Transformation Trends: What Innovations Are Driving Change?

Leading companies in the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on developing advanced solutions, such as sophisticated predictive modeling, to pinpoint high-risk patients, enable early interventions, and optimize care following discharge. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques on historical and real-time data to uncover intricate patterns and generate highly accurate forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, unveiled its AI-Powered Readmissions Management Solution, which integrates advanced predictive modeling to identify avoidable readmissions across Medicare, Medicaid, and uninsured populations. The platform also provides unified 360-degree patient views, agentic AI tools like Care Management Copilot and Pre-Call Coordinator Agent for workflow automation, and benchmark intelligence to aid proactive intervention planning. This solution assists healthcare providers in reducing readmission rates, improving resource allocation, and enhancing overall patient outcomes.

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx

View The Full Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report:

https://thebusinessresearchcompany.com/report/artificial-intelligence-ai-driven-hospital-readmission-predictor-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market CAGR Analysis And Future Market Development

The artificial intelligence (AI)-driven hospital readmission predictor market has seen rapid expansion in recent years. It is anticipated to grow from $1.92 billion in 2025 to $2.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.2%. The growth observed in the historic period is attributable to the increasing adoption of AI in healthcare, a growing demand to reduce hospital readmissions, the rising availability of electronic health records, the expansion of predictive analytics usage, and an increasing focus on patient outcomes.

The artificial intelligence (AI)-driven hospital readmission predictor market is anticipated to undergo significant expansion in the coming years. It is projected to achieve a size of $6.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 25.9%. This expansion throughout the forecast period is attributable to increasing investments in healthcare IT infrastructure, the growing incorporation of clinical decision support systems, the rising adoption of cloud-based analytics platforms, the broadening scope of remote patient monitoring tools, and an enhanced focus on value-based care models. Key trends during this period are expected to include technological advancements in machine learning models, innovations in real-time patient monitoring, research and developments in natural language processing, the creation of explainable AI specifically for healthcare, and improvements in interoperable healthcare IT systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

#Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Growth Drivers And Industry Catalysts

The growing incidence of chronic ailments is projected to boost the artificial intelligence (AI)-driven hospital readmission predictor market. Chronic diseases, defined as enduring health issues such as diabetes, heart disease, and arthritis, typically progress slowly and necessitate ongoing medical attention and lifestyle adjustments to manage symptoms and avert complications. The rise in these conditions is largely attributed to unhealthy lifestyle choices, including inadequate diet, physical inactivity, and smoking, which escalate the likelihood of ailments like diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors play a crucial role in chronic disease management by analyzing patient information to pinpoint individuals at high risk of readmission. They enhance patient outcomes by facilitating proactive interventions, tailored care plans, and timely follow-ups, thereby preventing complications and shortening hospital stays. For instance, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is fueling the expansion of the artificial intelligence (AI)-driven hospital readmission predictor market.

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Segmentation And Category Breakdown

The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud

3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools

2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices

3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services

#Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Trends Influencing Long-Term Demand

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are prioritizing the development of sophisticated solutions, such as advanced predictive modeling, to pinpoint high-risk patients, enable swift interventions, and optimize post-discharge care. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques on historical and real-time data to uncover intricate patterns and generate highly accurate forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, introduced its AI-Powered Readmissions Management Solution, which integrates advanced predictive modeling to identify avoidable readmissions among Medicare, Medicaid, and uninsured populations. The platform also delivers unified 360-degree patient views, agentic AI tools like Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence for planning proactive interventions. This solution supports healthcare providers in decreasing readmission rates, enhancing resource allocation, and improving overall patient outcomes.

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Competitive Analysis Of Major Industry Participants

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx

Access The Complete Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-driven-hospital-readmission-predictor-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Geographic Distribution And Regional Opportunities

North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The artificial intelligence (AI)-driven hospital readmission predictor market size has experienced significant growth in recent years. It is projected to expand from $1.92 billion in 2025 to $2.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.2%. This historical expansion can be attributed to the increasing adoption of AI in healthcare, a growing demand to reduce hospital readmissions, the rising availability of electronic health records, the expansion of predictive analytics usage, and an increasing focus on patient outcomes.

The artificial intelligence (AI)-driven hospital readmission predictor market size is expected to experience significant expansion over the next few years. It is anticipated to grow to $6.09 billion in 2030, achieving a compound annual growth rate (CAGR) of 25.9%. This growth in the forecast period can be attributed to factors such as increasing investments in healthcare IT infrastructure, the growing integration of clinical decision support systems, rising adoption of cloud-based analytics platforms, the expansion of remote patient monitoring tools, and a stronger emphasis on value-based care models. Key trends during this period include technological advancements in machine learning models, innovations in real-time patient monitoring, ongoing research and development in natural language processing, the creation of explainable AI for healthcare, and improvements in interoperable healthcare IT systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp

What Primary Factors Are Fueling The Expansion Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

The rising incidence of chronic diseases is anticipated to fuel the expansion of the artificial intelligence (AI)-driven hospital readmission predictor market in the future. Chronic illnesses are enduring health conditions that typically develop gradually, such as diabetes, heart disease, and arthritis, often requiring continuous medical care and lifestyle adjustments to manage symptoms and avert complications. These conditions are primarily increasing due to detrimental lifestyle choices, including poor diet, lack of physical activity, and smoking, which elevate the likelihood of ailments such as diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors assist in managing chronic illnesses by examining patient data to identify individuals prone to readmission. They enhance patient outcomes by facilitating early interventions, tailored treatment strategies, and prompt monitoring to prevent issues and shorten inpatient periods. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This marked an 18% increase from 3,065,825 cases in 2022. Consequently, the growing prevalence of chronic diseases is propelling the growth of the artificial intelligence (AI)-driven hospital readmission predictor market.

How Does Segment Analysis Break Down The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Structure?

The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud

3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools

2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices

3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services

What Trends Are Influencing The Future Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Companies active in the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on creating sophisticated solutions, including advanced predictive modeling, to identify patients at high risk, enable early interventions, and improve post-discharge care. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques on historical and real-time data to discover intricate patterns and generate highly accurate forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, introduced its AI-Powered Readmissions Management Solution, which incorporates advanced predictive modeling to pinpoint avoidable readmissions among Medicare, Medicaid, and uninsured populations. The platform also offers comprehensive 360-degree patient views, agentic AI tools such as Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence for proactive intervention strategies. This solution aids healthcare providers in reducing readmission rates, optimizing resource allocation, and enhancing overall patient outcomes.

Who Are The Leading Firms Participating In The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx

Access The Complete Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-driven-hospital-readmission-predictor-market-report

Which Region Is The Primary Market For The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai)-driven hospital readmission predictor market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market covering 2026–2035?

The market size for artificial intelligence (AI)-driven hospital readmission predictors has experienced significant expansion over recent years. This sector is anticipated to increase from $1.92 billion in 2025 to $2.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.2%. The historical drivers for this growth include the escalating integration of AI in healthcare, the heightened necessity to minimize hospital readmissions, the increasing presence of electronic health records, the wider deployment of predictive analytics, and an enhanced emphasis on patient welfare.

The artificial intelligence (AI)-driven hospital readmission predictor market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $6.09 billion, demonstrating a compound annual growth rate (CAGR) of 25.9%. This anticipated growth throughout the forecast period stems from several factors, including increased investments in healthcare information technology infrastructure, greater incorporation of clinical decision support systems, wider uptake of cloud-based analytics platforms, the broadening availability of remote patient monitoring instruments, and a heightened focus on value-based care frameworks. Key developments expected during this timeframe encompass technological progress in machine learning models, breakthroughs in real-time patient observation, intensified research and development efforts in natural language processing, the emergence of explainable AI solutions tailored for healthcare, and enhancements in interoperable healthcare IT systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

The expansion of the artificial intelligence (AI)-driven hospital readmission predictor market is anticipated to be driven by the rising occurrence of chronic diseases. These conditions are persistent health issues, like diabetes, heart disease, and arthritis, that typically advance gradually and necessitate continuous medical care and lifestyle adjustments to manage symptoms and avoid complications. Their growing frequency is primarily linked to unhealthy habits such as poor nutrition, lack of exercise, and smoking, which elevate the likelihood of developing conditions like diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors assist in managing chronic diseases by examining patient data to pinpoint individuals with a significant risk of readmission. These tools enhance patient results through proactive interventions, customized care plans, and prompt follow-ups, thereby preventing complications and shortening hospital admissions. As an illustration, the National Health Service, a UK-based government department, reported in June 2024 that 3,615,330 individuals registered with a general practitioner (GP) had received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar levels, not yet meeting the criteria for diabetes) in 2023. This represented an 18% rise from the 3,065,825 cases observed in 2022. Consequently, the rising incidence of chronic diseases is fostering the expansion of the artificial intelligence (AI)-driven hospital readmission predictor market.

What Leading Segments Are Studied In The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud

3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools

2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices

3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services

What Trends Are Projected To Support The Growth Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Companies active in the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on developing sophisticated solutions, such as advanced predictive modeling, to identify high-risk patients, facilitate proactive interventions, and improve post-discharge care. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques with historical and real-time data to uncover intricate patterns and generate highly precise forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, introduced its AI-Powered Readmissions Management Solution. This solution integrates advanced predictive modeling to pinpoint avoidable readmissions across Medicare, Medicaid, and uninsured populations. The platform also delivers unified 360-degree patient views, agentic AI tools including Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence for strategic intervention planning. This solution empowers healthcare providers to lower readmission rates, optimize resource allocation, and improve overall patient outcomes.

Which Leading Companies Dominate The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Share?

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-driven-hospital-readmission-predictor-market-report

How Does The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Perform Across Major Global Regions?

North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30521&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence In Healthcare Market 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-market

generative ai in healthcare global market report

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market During The Forecast Period?

The artificial intelligence (AI)-driven hospital readmission predictor market size has seen significant expansion in recent years. It is forecast to grow from $1.92 billion in 2025 to $2.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.2%. This historical growth can be attributed to several factors, including the increasing adoption of AI in healthcare, the escalating demand to reduce hospital readmissions, the rising availability of electronic health records, the broader expansion of predictive analytics usage, and a greater focus on improving patient outcomes.

The artificial intelligence (AI)-driven hospital readmission predictor market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $6.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 25.9%. This expected growth during the forecast period stems from factors such as increasing investments in healthcare IT infrastructure, enhanced integration of clinical decision support systems, wider adoption of cloud-based analytics platforms, the proliferation of remote patient monitoring tools, and a heightened focus on value-based care models. Key developments expected in this timeframe involve technological improvements in machine learning models, breakthroughs in real-time patient monitoring, advancements through research and development in natural language processing, the creation of explainable AI for medical applications, and progress in interoperable healthcare IT systems.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp

Which Important Drivers Are Guiding The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Growth?

The artificial intelligence (AI)-driven hospital readmission predictor market is anticipated to expand due to the rising occurrence of chronic diseases. These are persistent health conditions, such as diabetes, heart disease, and arthritis, which typically progress slowly over time and often require continuous medical attention and lifestyle adjustments to manage symptoms and prevent complications. The increase in chronic diseases is largely attributable to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which heighten the risk of developing conditions like diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors assist in chronic disease management by analyzing patient data to identify individuals at a high risk of readmission. They improve patient outcomes by enabling proactive interventions, personalized care plans, and timely follow-up to prevent complications and reduce hospital stays. For example, in June 2024, the National Health Service, a UK-based government department, stated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, which was an 18% increase from 3,065,825 cases in 2022. Hence, the increasing prevalence of chronic diseases is a key driver for the growth of the artificial intelligence (AI)-driven hospital readmission predictor market.

How Are Different Segments Classified In The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Segment Analysis?

The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud

3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools

2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices

3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services

What Trends Are Influencing The Evolution Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Leading firms within the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on creating sophisticated solutions, like advanced predictive modeling, aimed at pinpointing high-risk patients, facilitating early interventions, and enhancing post-discharge care. Advanced predictive modeling involves employing complex statistical algorithms and machine learning methods on both past and current data to reveal intricate patterns and produce very precise predictions of subsequent events. As an example, in July 2025, Innovaccer Inc., a US-based healthcare AI company, introduced its AI-Powered Readmissions Management Solution. This solution incorporates advanced predictive modeling to identify preventable readmissions across Medicare, Medicaid, and uninsured populations. Furthermore, the platform offers comprehensive 360-degree patient views, agentic AI tools including Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence to assist with proactive intervention strategies. This particular solution assists healthcare providers in decreasing readmission rates, optimizing resource distribution, and elevating overall patient results.

Who Are The Companies Driving Activity In The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx

Get The Full Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-driven-hospital-readmission-predictor-market-report

Which Region Is The Top Contributor To The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market By Share?

North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=30521&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence In Healthcare Market 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-market

generative ai in healthcare global market report

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Across 2026–2030?

The artificial intelligence (AI)-driven hospital readmission predictor market has seen significant expansion in recent years. Its size is forecast to increase from $1.92 billion in 2025 to $2.42 billion in 2026, reflecting a compound annual growth rate (CAGR) of 26.2%. This historical growth can be attributed to factors such as the rising incorporation of AI in healthcare, a growing imperative to decrease hospital readmissions, enhanced accessibility of electronic health records, the broader use of predictive analytics, and an intensified concentration on patient outcomes.

The market size for artificial intelligence (AI)-driven hospital readmission predictors is expected to experience substantial growth in the upcoming years. This market is projected to reach $6.09 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 25.9%. The anticipated growth during the forecast period can be attributed to increased investments in healthcare IT infrastructure, the expanding integration of clinical decision support systems, a wider adoption of cloud-based analytics platforms, the broadening use of remote patient monitoring tools, and a heightened focus on value-based care models. Prominent trends for the forecast period include technological advancements in machine learning models, new developments in real-time patient monitoring, ongoing research and development in natural language processing, the creation of explainable AI for healthcare, and improvements in interoperable healthcare IT systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

The expanding occurrence of chronic illnesses is anticipated to drive the advancement of the artificial intelligence (AI)-driven hospital readmission predictor market in the future. These conditions are enduring health issues, exemplified by diabetes, heart disease, and arthritis, which typically advance gradually and necessitate continuous medical care and lifestyle adjustments to manage symptoms and avert complications. Their rise is primarily linked to detrimental lifestyle choices, such as inadequate nutrition, lack of physical activity, and tobacco use, all of which elevate the likelihood of developing conditions like diabetes, heart disease, and obesity. Tools that predict hospital readmissions using artificial intelligence (AI) assist in managing chronic diseases by examining patient information to pinpoint individuals with a high probability of readmission. These tools enhance patient results through facilitating early interventions, customized treatment strategies, and prompt follow-up, thereby preventing complications and shortening hospital admissions. An illustrative example comes from the National Health Service, a UK government body, which reported in June 2024 that 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a state of elevated blood sugar not yet meeting diabetes criteria) in 2023, representing an 18% surge from 3,065,825 instances recorded in 2022. Consequently, the growing incidence of chronic illnesses is fostering the expansion of the artificial intelligence (AI)-driven hospital readmission predictor market.

What Segmentation Levels Are Considered In The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud

3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools

2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices

3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services

What Trends Are Projected To Affect The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Prominent companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on developing enhanced solutions, such as sophisticated predictive modeling, to pinpoint patients at high risk, enable proactive interventions, and optimize care following discharge. Sophisticated predictive modeling involves utilizing advanced statistical algorithms and machine learning methods on both historical and current data to uncover intricate patterns and produce very accurate forecasts of future outcomes. For example, in July 2025, Innovaccer Inc., a US-based healthcare AI company, unveiled its AI-Powered Readmissions Management Solution. This solution integrates advanced predictive modeling to highlight avoidable readmissions among Medicare, Medicaid, and uninsured populations. The platform also provides holistic 360-degree patient views, agentic AI tools like Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence for planning proactive interventions. This offering aids healthcare providers in reducing readmission rates, improving resource allocation, and elevating overall patient outcomes.

Which Leading Firms Are Contributing To The Growth Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx

Read the full artificial intelligence (ai)-driven hospital readmission predictor market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-driven-hospital-readmission-predictor-market-report

How Does The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Perform Across Major Global Regions?

North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30521&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Artificial Intelligence In Healthcare Market 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-market

generative ai in healthcare global market report

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model